Skip to main content

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Top User Menu

  • CME
  • Register
  • Login
Advertisement

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
    • Hearts & Minds
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum
  • News (246)
  • Slides (5)
  • CME (2)
  • Biographies (1)
Videos
Podcast
  • Daily News
  • Conference News
  • Industry News
  • Editor's Corner
  • Features
  • CV Team Dispatch
  • ACC (20)
  • EAS (19)
  • AHA (15)
  • ESC (10)
  • TCT (3)
  • Complex Coronary Cases (1)
  • EuroPCR (1)
  • HRS (1)
  • ISC (1)
  • SCAI (1)
  • SCCT (1)
  • Clinical Cardiology (184)
  • Lipids (159)
  • Prevention (127)
  • Clinical Pharma (124)
  • Coronary (120)
  • Policy & Practice (88)
  • CAD Pharma (87)
  • ACS/AMI (74)
  • Public Health (51)
  • Guidelines (34)
  • Diabetes (33)
  • Hypertension (33)
  • Obesity (21)
  • Heart Failure (16)
  • Plaque Modification (16)
  • Women's Heart (16)
  • Imaging & Physiology (13)
  • Approvals (11)
  • Cath Lab (9)
  • Heart Rhythm (9)
  • Stroke (9)
  • Structural Heart (9)
  • Endovascular (8)
  • DES/BRS/DCB (7)
  • Aortic Valve (6)
  • Quality (5)
  • Heart Failure Pharma (4)
  • Cardiac Surgery (3)
  • Angiography/QCA (2)
  • Atrial Fibrillation (2)
  • COVID-19 (2)
  • CT/CT-FFR (2)
  • Hypertrophic Cardiomyopathy (2)
  • IVUS/NIRS (2)
  • Popliteal/Infrapopliteal (2)
  • Alerts (1)
  • Congenital (1)
  • CTO (1)
  • Echo (1)
  • FFR (1)
  • OCT (1)
  • Pacing/ICDs (1)
  • PFO/ASD (1)
  • Training (1)
  • Vascular Access/Closure (1)
  • 2025 (6)
  • 2024 (18)
  • 2023 (23)
  • 2022 (29)
  • 2021 (20)
  • 2020 (19)
  • 2019 (27)
  • 2018 (15)
  • 2017 (11)
  • 2016 (74)
Displaying 101 - 120 of 254
Sort: Relevancy | Date
New STRENGTH Analysis Revives Omega-3 Debate
News Conference News ACC 2021

New STRENGTH Analysis Revives Omega-3 Debate

Todd Neale
Todd Neale
May 20, 2021
Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia
News Conference News ACC 2021

Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia

Yael L. Maxwell
Yael L. Maxwell
May 16, 2021
Outcomes Worse for STEMI Patients Without Obvious Risk Factors
News Daily News

Outcomes Worse for STEMI Patients Without Obvious Risk Factors

Todd Neale
Todd Neale
March 12, 2021
Daily Fruit and Vegetable Intake Linked to Lower Mortality
News Daily News

Daily Fruit and Vegetable Intake Linked to Lower Mortality

L.A. McKeown
L.A. McKeown
March 04, 2021
Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval
News Daily News

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Michael O'Riordan
Michael O'Riordan
March 03, 2021
Mom’s CV Health in Pregnancy Foretells Child’s Risk Years Later
News Daily News

Mom’s CV Health in Pregnancy Foretells Child’s Risk Years Later

L.A. McKeown
L.A. McKeown
February 17, 2021
FDA Approves Evinacumab for Rare Homozygous FH
News Daily News

FDA Approves Evinacumab for Rare Homozygous FH

Michael O'Riordan
Michael O'Riordan
February 11, 2021
FDA Passes on Inclisiran, Citing Manufacturing Site Problems
News Daily News

FDA Passes on Inclisiran, Citing Manufacturing Site Problems

Shelley Wood
Shelley Wood
December 23, 2020
AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More
News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood
Shelley Wood
December 17, 2020
Inclisiran Approved in Europe for Lowering LDL Cholesterol
News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan
Michael O'Riordan
December 11, 2020
Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention
News Conference News EAS 2020

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Michael O'Riordan
Michael O'Riordan
October 08, 2020
Higher Risk of HF After ACS for Women Previously on Beta-blockers
News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan
Michael O'Riordan
July 16, 2020
PAD Patients Undertreated With Statins Despite Elevated CV Risk
News Daily News

PAD Patients Undertreated With Statins Despite Elevated CV Risk

L.A. McKeown
L.A. McKeown
July 13, 2020
Bempedoic Acid Safe, Lowers LDL in Hypercholesterolemia: Pooled RCT Data
News Daily News

Bempedoic Acid Safe, Lowers LDL in Hypercholesterolemia: Pooled RCT Data

Yael L. Maxwell
Yael L. Maxwell
July 07, 2020
US Poverty Drives CVD in Low-Income Adults Beyond Traditional Risk Factors
News Daily News

US Poverty Drives CVD in Low-Income Adults Beyond Traditional Risk Factors

L.A. McKeown
L.A. McKeown
May 28, 2020
Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades
News Daily News

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Yael L. Maxwell
Yael L. Maxwell
May 28, 2020
COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention
News Features

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Michael O'Riordan
Michael O'Riordan
April 24, 2020
Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH
News Conference News ACC 2020

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

Yael L. Maxwell
Yael L. Maxwell
April 06, 2020
Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events
News Conference News ACC 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Michael O'Riordan
Michael O'Riordan
April 02, 2020
Hope for these hard-to-treat patients: more than half saw ≥ 50% decrease at 24 weeks, regardless of LDL receptor function.
News Conference News ACC 2020

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Yael L. Maxwell
Yael L. Maxwell
April 01, 2020

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Current page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Next page ››
  • Last page Last »
Advertisement
Become a Member

Register for TCTMD ®

Membership Plans
Sign Up for Our Newsletter

Receive the the latest news, research, and presentations from major meetings right to your inbox.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives. For more information, visit http://www.crf.org.

Main Navigation

  • News
  • Conferences
  • Slides
  • Videos
  • Podcasts
  • Fellows Forum
  • CV Team Forum
  • CME

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Footer

  • Advertising & Sponsorships
  • About TCTMD ®
  • FAQs
  • Editorial Policy
  • Contact Us
  • About CRF ®
Digital Health Awards Winner - Spring 2017 eHealthcare Leadership Awards - 2018 Winner HON Code Certified
Copyright © 2026. TCTMD ® All rights reserved.
  • Privacy Policy
  • Terms of Use
Created by Constructive
Sign In

New at TCTMD? Register today!

Forgot Password

Forgot Your Password?

Enter the email you used to register to reset your password.

Search TCTMD
cme
CME TITLE
Sign up for our newsletter

Sign up to receive the most important cardiovascular news, research, and major meeting presentations.

Address
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
    • Hearts & Minds
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum

Top User Menu

  • CME
  • Register
  • Login

Search TCTMD

Submit an Event
< >

Become a PREMIUM MEMBER or LOG IN to view exclusive content

This content is available for meeting attendees and/or Platinum Members

REGISTER for free or LOG IN to view this content

Now Playing